2022
DOI: 10.1038/s41374-021-00715-1
|View full text |Cite
|
Sign up to set email alerts
|

SIRT6 regulates SREBP1c-induced glucolipid metabolism in liver and pancreas via the AMPKα-mTORC1 pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 20 publications
(14 citation statements)
references
References 39 publications
0
14
0
Order By: Relevance
“…41,42 Moreover, PPAR-α and SREBP1-c, i.e., the major genes controlling fatty acid synthesis and oxidation, regulate the hepatic lipid metabolism in ALD. 14,15 Interestingly, SIRT6 improves glucose and lipid metabolism by regulating PPAR-α and SREBP1-c. 40,68 After observing H&E-and Oil Red O-stained slides and measuring the expression of β-oxidationand lipid synthesis-related genes, we found that ginsenoside Rc reversed alcohol-induced hepatic steatosis. In keeping with our findings, the ginsenoside Rcinduced mitigation of lipid accumulation was abolished by SIRT6's deficiency.…”
Section: ■ Discussionmentioning
confidence: 90%
See 1 more Smart Citation
“…41,42 Moreover, PPAR-α and SREBP1-c, i.e., the major genes controlling fatty acid synthesis and oxidation, regulate the hepatic lipid metabolism in ALD. 14,15 Interestingly, SIRT6 improves glucose and lipid metabolism by regulating PPAR-α and SREBP1-c. 40,68 After observing H&E-and Oil Red O-stained slides and measuring the expression of β-oxidationand lipid synthesis-related genes, we found that ginsenoside Rc reversed alcohol-induced hepatic steatosis. In keeping with our findings, the ginsenoside Rcinduced mitigation of lipid accumulation was abolished by SIRT6's deficiency.…”
Section: ■ Discussionmentioning
confidence: 90%
“…Reports indicate that under the action of hepatic drug-metabolizing enzymes, alcohol induces the generation of free radicals, which consume the antioxidants present in liver cells, causing the rapid accumulation of large amounts of TG in the same cells and, hence, liver steatosis. , Moreover, PPAR-α and SREBP1-c, i.e., the major genes controlling fatty acid synthesis and oxidation, regulate the hepatic lipid metabolism in ALD. , Interestingly, SIRT6 improves glucose and lipid metabolism by regulating PPAR-α and SREBP1-c. , After observing H&E- and Oil Red O-stained slides and measuring the expression of β-oxidation- and lipid synthesis-related genes, we found that ginsenoside Rc reversed alcohol-induced hepatic steatosis. In keeping with our findings, the ginsenoside Rc-induced mitigation of lipid accumulation was abolished by SIRT6’s deficiency.…”
Section: Discussionmentioning
confidence: 99%
“…Sirtuins are other regulators slowing cell and organism aging [ 42 , 43 , 44 ], although the precise mechanisms by which this is attained are unclear. Sirtuins can modulate cell metabolic state and proteostasis at different levels [ 42 , 45 , 46 , 47 , 48 ], as well as counteract genome reprogramming [ 49 , 50 ]. Sirtuins were proven to exert an anti-aging effect on skin components, reducing inflammaging and promoting autophagy [ 51 ].…”
Section: Discussionmentioning
confidence: 99%
“…AMPK is a key molecule in the regulation of biological energy metabolism. Our previous research found that SIRT6 regulated sterol regulatory element-binding protein 1c mediated glucolipid metabolism in the liver and pancreas through AMPKα-mTORC1 ( 147 ). In the DKD study, SIRT1 regulated podocyte fatty acid synthesis via AMPK-SREBP1 ( 92 ), podocyte inflammation by AMPK-NFκB ( 90 ), glucolipid metabolism, and mitochondrial function by AMPK-PGC1α ( 82 ), fibronectin in mesangial matrix deposition ( 94 ), and protein synthesis and mesangial cell hypertrophy through AMPK-mTOR ( 97 ).…”
Section: Role Of the Sirtuin Family In Diabetic Kidney Diseasementioning
confidence: 99%